DHI Relative Valuation
DHI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DHI is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for DHI's competitors is 1.20, providing a benchmark for relative valuation. DR Horton Inc Corp (DHI) exhibits a P/S ratio of 1.13, which is -5.85% above the industry average. Given its robust revenue growth of -15.08%, this premium appears unsustainable.
People Also Watch
BKR
Baker Hughes Co
37.340
USD
-1.50%
D
Dominion Energy Inc
58.000
USD
+3.20%
FLUT
Flutter Entertainment PLC
246.890
USD
-0.99%
HES
Hess Corp
132.050
USD
-0.56%
DDOG
Datadog Inc
116.290
USD
-0.15%
FICO
Fair Isaac Corp
2027.000
USD
-8.11%
COR
Cencora Inc
292.930
USD
+0.10%
DFS
Discover Financial Services
0
USD
-0.21%
TRGP
Targa Resources Corp
161.930
USD
-1.64%
AIG
American International Group Inc
84.080
USD
-0.31%
FAQ
Is DR Horton Inc (DHI) currently overvalued or undervalued?
DR Horton Inc (DHI) is now in the Fair zone, suggesting that its current forward PE ratio of 11.08 is considered Fairly compared with the five-year average of 8.56. The fair price of DR Horton Inc (DHI) is between 81.44 to 124.85 according to relative valuation methord.
What is DR Horton Inc (DHI) fair value?
How does DHI's valuation metrics compare to the industry average?
What is the current P/B ratio for DR Horton Inc (DHI) as of May 21 2025?
What is the current FCF Yield for DR Horton Inc (DHI) as of May 21 2025?
What is the current Forward P/E ratio for DR Horton Inc (DHI) as of May 21 2025?